Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exeter Communications was a boutique strategic communications and investor relations firm that specialized in the life sciences, biotechnology, and healthcare sectors. The firm provided specialized public relations and corporate positioning services to emerging and established biotech companies, often facilitating media outreach and investor engagement during critical clinical or financial milestones. While the firm was active in the early to mid-2000s, representing notable clients such as Aastrom Biosciences and Genzyme, it is no longer a prominent active entity in the current biotech landscape. Its primary value proposition was bridging the gap between complex scientific data and the investment community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exeter Communications.